Affect lability and Vitreous floaters

Summary:

Vitreous floaters is reported only by a few people with Affect lability.

The study analyzes which people have Vitreous floaters with Affect lability. It is created by eHealthMe based on 1 person who has Vitreous floaters and Affect lability from the Food and Drug Administration (FDA), and is updated regularly.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 787 drugs and 810 conditions by eHealthMe. Check the latest studies of Affect lability.

What is Vitreous floaters?

Vitreous floaters (spots before the eyes) is found to be associated with 878 drugs and 829 conditions by eHealthMe. Check the latest studies of Vitreous floaters.

On Dec, 22, 2025

1 person who has Affect Lability and Vitreous Floaters is studied.

Would you have Vitreous floaters when you have Affect lability?

Gender of people who have Affect Lability and experienced Vitreous Floaters *:

female: 100 %
male: 0.0 %

Age of people who have Affect Lability and experienced Vitreous Floaters *:

Common drugs taken by these people *:

Click here to view

Common symptoms for these people *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Vitreous floaters?

- Check whether Vitreous floaters is associated with a drug or a condition (FREE)

Related studies:

Treatments, associated drugs and conditions:

Affect lability (13,491 reports)
Vitreous floaters (10,893 reports)

All the drugs that are associated with Vitreous floaters:

Vitreous floaters (878 drugs)

All the conditions that are associated with Vitreous floaters:

Vitreous floaters (829 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Vitreous floaters and Affect lability, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.